EMA head forced to step down
This article was originally published in Scrip
Guido Rasi, executive director of the European Medicines Agency, has had to step down from his position after the EU's civil service tribunal annulled the European Commission's 2011 decision establishing a shortlist of candidates for the post. The judgment means that the decision by the EMA's management board to select Professor Rasi from the shortlist and appoint him executive director on 6 October 2011 has also been annulled.
You may also be interested in...
New guidance from the UK covers the recognition of EU approvals, accelerated assessment, rolling reviews, and much else besides.
As negotiations between the UK and EU enter a crucial phase, the UK life sciences industry has called for more clarity and guidance on what companies can expect to face at the end of the Brexit transition period.
A legislative provision under which future COVID-19 vaccines can be made available in the UK before they are approved is also being used to offer an unlicensed flu vaccine that officials say has undergone full safety, efficacy and quality tests.